These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11134797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Islet autoantibodies and their use in predicting insulin-dependent diabetes.
    Bonifacio E, Bingley PJ.
    Acta Diabetol; 1997 Oct; 34(3):185-93. PubMed ID: 9401639
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C.
    Journ Annu Diabetol Hotel Dieu; 1992 Oct; ():165-71. PubMed ID: 1495236
    [No Abstract] [Full Text] [Related]

  • 9. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T, Nakanishi K, Murase T, Kosaka K.
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract] [Full Text] [Related]

  • 10. Combined antibody screening for improved prediction of IDDM--modern strategies.
    Roll U, Ziegler AG.
    Exp Clin Endocrinol Diabetes; 1997 Oct; 105(1):1-14. PubMed ID: 9088889
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G, Bazzigaluppi E, Mangili R, Bosi E, Bonifacio E.
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract] [Full Text] [Related]

  • 12. Selecting culprits in type 1 diabetes beta-cell killing.
    Lernmark A.
    J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509
    [No Abstract] [Full Text] [Related]

  • 13. Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies.
    Lernmark A, Kolb H, Mire-Sluis T.
    Diabetologia; 1999 Mar; 42(3):381-2. PubMed ID: 10096794
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A diabetes potpourri, Part 1.
    Bloomgarden ZT.
    Diabetes Care; 1995 May; 18(5):734-6. PubMed ID: 8586018
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Response to Bazzigaluppi et al.: capillary whole-blood measurement of islet autoantibodies.
    Costa A, Conget I, Casamitjana R.
    Diabetes Care; 2000 Jun; 23(6):874. PubMed ID: 10841023
    [No Abstract] [Full Text] [Related]

  • 19. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M, Ziegler B.
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract] [Full Text] [Related]

  • 20. Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.
    Mujtaba MA, Fridell J, Book B, Faiz S, Sharfuddin A, Wiebke E, Rigby M, Taber T.
    Clin Transplant; 2015 Nov; 29(11):991-6. PubMed ID: 26289931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.